Post by
4marlin on May 01, 2024 10:03am
Withdrawal of previously announced assay results
This is not helpful at all.
Hopefully the ´inconsistencies´ are not major.
Totally unexpected/weird.
Bb
Comment by
rigpig99 on May 01, 2024 10:05am
Hopefully they have underestimated their results.
Comment by
bugsy46 on May 01, 2024 10:44am
I'm taking this as a positive. For RB RPX to do an audit on the inconsistencies I'm thinking that it could hopefully turn out to be positive. Some investors are getting a nice cheap stock price right now. Just my opinion
Comment by
Nick2021 on May 01, 2024 11:32am
It looks pretty bad -- the ex CEO resigned suddenly in February, then quit the BOD two weeks ago -- they were the person who signed off on the reports in question.
Comment by
MrDales62 on May 01, 2024 11:41am
How to kill a company 101. Class action lawsuits on the way? GLTA
Comment by
roberto146 on May 01, 2024 1:18pm
FNV, ASA, and AGI have put subtantial dollars into this in the last year and they usually don't do that without looking at DD/data and consideration of the history of the region. I'd say it's worth a wait-and-see and worth a gamble at this historic distressed price. There will be all hands on deck to find out what's what.
Comment by
FlightTime on May 01, 2024 1:43pm
Agreed. As vague as the press release was, the interest from external parties who have a stake in RPX should hopefully provide some support.